1.0849
price down icon3.13%   -0.0351
 
loading
전일 마감가:
$1.12
열려 있는:
$1.1
하루 거래량:
1.10M
Relative Volume:
0.62
시가총액:
$165.78M
수익:
$137.74M
순이익/손실:
$-27.97M
주가수익비율:
-0.9273
EPS:
-1.17
순현금흐름:
$-9.61M
1주 성능:
-12.50%
1개월 성능:
-40.06%
6개월 성능:
-68.46%
1년 성능:
-17.18%
1일 변동 폭
Value
$1.05
$1.12
1주일 범위
Value
$1.05
$1.255
52주 변동 폭
Value
$1.04
$3.93

Heron Therapeutics Inc Stock (HRTX) Company Profile

Name
명칭
Heron Therapeutics Inc
Name
전화
(858) 251-4400
Name
주소
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Name
직원
126
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
HRTX's Discussions on Twitter

HRTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
HRTX 1.085 165.78M 137.74M -27.97M -9.61M -1.17
VRTX 450.35 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.65 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.59 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.57 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.09 24.89B 3.30B -501.07M 1.03B 11.54

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-05-27 개시 Guggenheim Buy
2020-02-20 재확인 Needham Buy
2019-01-16 재확인 Needham Buy
2018-04-05 개시 Evercore ISI Outperform
2018-03-19 재확인 Mizuho Buy
2018-03-01 재확인 Needham Buy
2018-01-03 개시 Leerink Partners Outperform
2017-09-27 개시 Northland Capital Outperform
2017-02-27 개시 Needham Buy
2016-10-26 개시 Aegis Capital Buy
2016-09-06 재개 Lake Street Buy
2016-05-03 개시 Cantor Fitzgerald Buy
2015-12-10 개시 Lake Street Buy
2015-09-23 재확인 Leerink Partners Outperform
2015-09-02 개시 BofA/Merrill Buy
2015-08-03 재확인 Brean Capital Buy
2015-06-30 재확인 JMP Securities Mkt Outperform
2015-06-19 재확인 Leerink Partners Outperform
2014-08-07 개시 Noble Financial Buy
모두보기

Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스

pulisher
03:39 AM

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to "Hold" - MarketBeat

03:39 AM
pulisher
Nov 20, 2024

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Heron Therapeutics Q3 2024 Earnings Preview - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Heron Therapeutics Inc (NASDAQ: HRTX) Declines -1.68%: This $177.95 million Stock Could Go Down -669.23% - Stocks Register

Nov 19, 2024
pulisher
Nov 18, 2024

Short Interest in Heron Therapeutics, Inc. (NASDAQ:HRTX) Declines By 6.0% - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Northland Capmk Has Pessimistic View of HRTX Q4 Earnings - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

Equities Analysts Set Expectations for HRTX Q4 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Heron Therapeutics (NASDAQ:HRTX) Raised to Buy at StockNews.com - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Heron Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St

Nov 14, 2024
pulisher
Nov 13, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Needham & Company LLC Has Lowered Expectations for Heron Therapeutics (NASDAQ:HRTX) Stock Price - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Why Investors Shouldn't Be Surprised By Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 30% Share Price Plunge - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Heron Therapeutics Inc (HRTX) Quarterly 10-Q Report - Quartzy

Nov 13, 2024
pulisher
Nov 13, 2024

Investors Don't See Light At End Of Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Tunnel And Push Stock Down 30% - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Heron Therapeutics projects higher Q4 revenue By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 12, 2024

Heron Therapeutics Reports Q3 2024 Results and Narrows Guidance - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics: Q3 Earnings Snapshot - CT Insider

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics reports Q3 EPS (3c), consensus (3c) - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PR Newswire

Nov 12, 2024
pulisher
Nov 10, 2024

Heron Therapeutics (HRTX) Set to Announce Earnings on Tuesday - Defense World

Nov 10, 2024
pulisher
Nov 07, 2024

Unveiling Heron Therapeutics (HRTX) Q3 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance

Nov 07, 2024
pulisher
Nov 05, 2024

Heron Therapeutics (HRTX) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Positive Signs As Multiple Insiders Buy Heron Therapeutics Stock - Yahoo Finance UK

Nov 05, 2024
pulisher
Nov 04, 2024

Heron Therapeutics Strengthens Leadership with New Board Appointment - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - StockTitan

Nov 04, 2024
pulisher
Oct 31, 2024

Bunion Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Heron Therapeutics, Lotus Clinical Research, Cali Pharma, Grünenthal GmbH, Pacira Pharma, Inc, Mallinckrodt - The Globe and Mail

Oct 31, 2024
pulisher
Oct 29, 2024

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - Longview News-Journal

Oct 29, 2024
pulisher
Oct 26, 2024

SG Americas Securities LLC Cuts Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 26, 2024
pulisher
Oct 21, 2024

Antinauseants Market Insights, Forecast to 2031Heron - openPR

Oct 21, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 6,328 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 20, 2024
pulisher
Oct 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Heron Therapeutics Inc (HRTX) deserves deeper analysis - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Investor’s Toolkit: Key Ratios for Assessing Heron Therapeutics Inc (HRTX)’s Performance - The Dwinnex

Oct 14, 2024
pulisher
Oct 12, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Congress Park Capital LLC - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - The Malaysian Reserve

Oct 10, 2024
pulisher
Oct 09, 2024

Its Stock Has Paid Off Big Time For Heron Therapeutics Inc - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

AQR Capital Management LLC Raises Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Heron Therapeutics Inc Inc. (HRTX) Price Performance: The Role of Supply and Demand - The InvestChronicle

Oct 08, 2024
pulisher
Oct 08, 2024

Can you now get a good deal on Heron Therapeutics Inc’s shares? - US Post News

Oct 08, 2024
pulisher
Oct 06, 2024

Squarepoint Ops LLC Purchases 286,160 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 06, 2024
pulisher
Oct 03, 2024

Buying Buzz: Heron Therapeutics Inc [HRTX] EVP, Chief Development Officer Forbes William P purchases 25,000 shares of the company – Knox Daily - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

HRTX’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

When Can We Expect A Profit From Heron Therapeutics, Inc. (NASDAQ:HRTX)? - Simply Wall St

Oct 03, 2024
pulisher
Oct 02, 2024

Get in on Heron Therapeutics Inc’s (HRTX) buy-in window today! - SETE News

Oct 02, 2024
pulisher
Oct 02, 2024

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - Yahoo Finance

Oct 02, 2024

Heron Therapeutics Inc (HRTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):